ACME Resources Corp. Amends Letter of Intent with Hantian Labs Limited in respect of a Qualifying Transaction

Toronto, Ontario--(Newsfile Corp. - March 31, 2016) - ACME Resources Corp. (TSXV: ACY.H) ("ACME"), a capital pool company trading on the NEX Exchange with symbol ACY.H, wishes to announce that it has amended its original letter of intent dated December 7, 2015, (the "LOI"), with Hantian Labs Limited, a private UK corporation ("Hantian" or "Hantian Labs"), for a business transaction that will result in a reverse take-over of ACME by Hantian, and the listing or trade of the shares of the resulting issuer (the "ResultingIssuer") on the TSXV (the "Transaction"). The LOI was originally announced on December 11, 2015 with a First Amendment to the LOI being announced on January 29, 2016.

ACME and Hantian have agreed to extend the settlement of a Definitive Agreement until July 31, 2016 and the closing of the Transaction until October 31, 2016. As per the First Amendment, the LOI was to terminate in the event the parties failed to enter into a Definitive Agreement on or prior to March 31, 2016, unless a later date was otherwise mutually agreed to by the parties.

The Transaction is subject to TSX Venture Exchange ("TSXV") approval and is intended to constitute the Qualifying Transaction of ACME as such term is defined in Policy 2.4 of the TSXV. It is intended that the Transaction shall be completed by way of a definitive merger, amalgamation or share exchange agreement, provided however that, by mutual agreement, the parties may revise the structure to comply with all necessary legal and regulatory requirements, to minimize or eliminate any adverse tax consequences or to increase cost effectiveness. The Transaction is intended to result in a reverse take-over of ACME by Hantian's shareholders. The Transaction will be an Arm's Length Qualifying Transaction, as defined in the policies of the TSXV and, as such, it is not anticipated that the formal approval of the shareholders of ACME will be required.

ACME currently has 4,101,950 common shares issued and outstanding and 247,168 stock options outstanding. ACME's common shares have been halted from trading and will remain halted until the documentation required by the TSXV for the proposed Transaction can be provided to the TSXV.

ACME RESOURCES CORP.                                        

Paul R. Ankcorn                              
Chief Executive Officer                  
                    
Telephone: (416) 360-8006                                     

HANTIAN LABS LIMITED

Christian Diesveld
Managing Director

Telephone: (647)938-6475

Completion of the Transaction issubjecttoanumberofconditions, including but not limited to, TSXVacceptanceand,ifapplicablepursuanttoTSXVrequirements, majorityoftheminority approvaloftheshareholdersofACME. Whereapplicable,theTransactioncannotcloseuntil therequiredshareholderapproval is obtained. There can be no assurance that the Transaction will be completed as proposed or at all.

Investorsarecautionedthat,exceptasdisclosedinthemanagementinformationcircularor filingstatementtobepreparedinconnectionwith the Transaction, any information released or receivedwithrespecttotheTransactionmaynotbeaccurateorcompleteandshouldnotbe relied upon. Trading in the securities of a capital pool company should be considered highly speculative.

The TSXV has in no way passed upon the meritsof the proposed Transaction and has neither approved nor disapproved thecontents of this press release.Neither the TSXV nor its RegulationServicesProvider(asthattermisdefinedinthepoliciesoftheTSXV) accepts responsibility for the adequacy or accuracyofthisrelease.

This press release contains forward-looking information within the meaning of Canadian securitieslaws.Suchinformationincludes, withoutlimitation,informationregardingthe completionoftheproposedTransaction,the concurrent financing, and the anticipated business plan of ACME subsequent to completion of theTransaction. AlthoughACMEbelievesthatsuchinformationisreasonable,itcangiveno assurance that such expectations will prove to be correct.

Forwardlookinginformationistypicallyidentifiedbywordssuchas:believe,expect, anticipate, intend,estimate,postulateandsimilarexpressions,or are those, which, by their nature, refer to futureevents. ACMEcautionsinvestorsthatanyforward-lookinginformationprovidedby ACME are not guarantees of futureresults or performance, and that actual results may differ materiallyfromthoseinforwardlookinginformationasaresultofvariousfactors,including, butnotlimitedto:ACME'sabilitytocompletetheproposedTransaction;thestateofthe financial markets for ACME's equity securities; the state of the market for bio-tech products or other productsthatmaybeproducedgenerally bythe resultingissuerintheeventtheTransactionis completed;recentmarketvolatility; ACME'sabilitytoraisethenecessarycapitalortobefully able to implement its business strategies; and other risks and factorsthat ACME is unaware of at thistime. ThereaderisreferredtoACME'smostrecentannualandinterimManagement's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through ACME's page on SEDAR at www.sedar.com.